Explore
Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer
0 Ungluers have
Faved this Work
Login to Fave
This Special Issue in Cancers is focused on cell therapy, bispecific antibodies, and other immunotherapies against cancer. It includes reports on cell therapies such as CAR-NK cell therapies, and bispecific antibodies against multiple myeloma and B cell lymphoma. Immunotherapies against solid tumors include TGF-beta-PDL-1 fusion protein and EpCAM-CD3 bispecific antibody generated with mRNA-lipid nanoparticles (LNP) against colorectal tumors. The clinical studies ongoing with bi- and tri-specific T cell engager antibodies against solid tumors and advantages versus cell therapies are discussed. This Special Issue highlights novel approaches to cell therapies, bispecific antibodies, vaccines, and immunotherapies that will be interesting for cancer cell researchers, biologists, and oncologists.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 12 times via unglue.it ebook links.
- 12 - pdf (CC BY) at Unglue.it.
Keywords
- bispecific antibody
- Cancer
- cell therapy
- chimeric antigen receptor
- Clinical & internal medicine
- Diseases & disorders
- Immunotherapy
- medicine
- oncology
- Vaccine
Links
DOI: 10.3390/books978-3-0365-9567-2Editions